This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (28)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Topic Collections  • Obesity  • Alert me on articles by topic  Social Bookmarking   What's this?

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: Davì et al¹ recently reported that android obesity is associated with enhanced lipid peroxidation and persistent platelet activation, both of which can be reduced by weight loss. In this context, enhanced circulating soluble CD40 ligand (CD40L) has recently been suggested to be associated with platelet activation.^2-4 CD40L is a trimeric, transmembrane protein of the tumor necrosis factor family that is cryptic in unstimulated platelets but is rapidly expressed on the platelet surface after platelet stimulation.³ Thus, increased levels of circulating soluble CD40L represent an index of platelet activation.^2-4 We assessed the relationship between central obesity and levels of circulating soluble CD40L and the effect of weight loss on this measure of platelet activation.

Methods

Participants were 36 obese white men (mean age, 53.4 [SD, 6.6] years) with body mass indexes (BMIs) greater than 30 and without additional cardiovascular risk factors, selected according to previously described criteria.⁵ All patients . . . [Full Text of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The Proinflammatory Mediator CD40 Ligand Is Increased in the Metabolic Syndrome and Modulated by Adiponectin
Natal et al.
J. Clin. Endocrinol. Metab. 2008;93:2319-2327.
ABSTRACT | FULL TEXT  

Cardiotrophin-1 is expressed in adipose tissue and upregulated in the metabolic syndrome
Natal et al.
Am. J. Physiol. Endocrinol. Metab. 2008;294:E52-E60.
ABSTRACT | FULL TEXT  

Insulin Resistance as a Determinant of Platelet Activation in Obese Women
Basili et al.
J Am Coll Cardiol 2006;48:2531-2538.
ABSTRACT | FULL TEXT  

Early Activation of Vascular Endothelial Cells and Platelets in Obese Children
Desideri et al.
J. Clin. Endocrinol. Metab. 2005;90:3145-3152.
ABSTRACT | FULL TEXT  

Hypertension and Obesity
Aneja et al.
Recent Prog Horm Res 2004;59:169-205.
ABSTRACT | FULL TEXT